UnitedHealth Group (NYSE:UNH) had its price target raised by Barclays from $260.00 to $305.00 in a report issued on Monday morning, The Fly reports. They currently have an overweight rating on the healthcare conglomerate’s stock.
Several other equities research analysts have also recently weighed in on UNH. Deutsche Bank began coverage on shares of UnitedHealth Group in a research note on Thursday, September 12th. They issued a hold rating and a $263.00 target price for the company. Mizuho restated a buy rating and set a $300.00 price target (up from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Citigroup cut their price target on UnitedHealth Group from $299.00 to $286.00 and set a buy rating for the company in a report on Wednesday, October 16th. SunTrust Banks reiterated a buy rating and issued a $335.00 price objective (up previously from $310.00) on shares of UnitedHealth Group in a research report on Monday, November 18th. Finally, Jefferies Financial Group lowered UnitedHealth Group from a buy rating to a hold rating and decreased their price objective for the stock from $300.00 to $235.00 in a report on Thursday, October 10th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus price target of $289.39.
Shares of UNH stock opened at $279.66 on Monday. The firm has a market capitalization of $265.15 billion, a P/E ratio of 21.71, a price-to-earnings-growth ratio of 1.48 and a beta of 0.64. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $287.94. The firm’s fifty day simple moving average is $258.05 and its 200 day simple moving average is $245.34. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The firm had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. During the same period in the prior year, the company earned $3.41 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group will post 14.96 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date is Friday, December 6th. UnitedHealth Group’s payout ratio is 33.54%.
In related news, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the completion of the transaction, the chief accounting officer now owns 21,687 shares in the company, valued at approximately $5,531,052.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 25,000 shares of the business’s stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of $236.56, for a total value of $5,914,000.00. Following the completion of the sale, the director now directly owns 163,331 shares in the company, valued at approximately $38,637,581.36. The disclosure for this sale can be found here. Over the last quarter, insiders sold 38,577 shares of company stock worth $9,398,080. Corporate insiders own 0.82% of the company’s stock.
A number of large investors have recently made changes to their positions in the business. Northern Trust Corp boosted its position in UnitedHealth Group by 0.4% in the second quarter. Northern Trust Corp now owns 12,111,540 shares of the healthcare conglomerate’s stock valued at $2,955,336,000 after buying an additional 53,710 shares in the last quarter. Nuveen Asset Management LLC raised its stake in shares of UnitedHealth Group by 1,354.6% in the second quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock valued at $2,083,983,000 after acquiring an additional 7,953,416 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of UnitedHealth Group by 16.7% in the 2nd quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock worth $1,573,438,000 after acquiring an additional 922,290 shares in the last quarter. Viking Global Investors LP boosted its holdings in shares of UnitedHealth Group by 28.6% in the 2nd quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock worth $1,174,221,000 after acquiring an additional 1,071,149 shares in the last quarter. Finally, Longview Partners Guernsey LTD grew its position in UnitedHealth Group by 9.9% during the 2nd quarter. Longview Partners Guernsey LTD now owns 3,752,630 shares of the healthcare conglomerate’s stock worth $915,679,000 after acquiring an additional 338,097 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Percentage Gainers
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.